Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marseille

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
The Lancet. Global Health|October 12, 2014
Avahan and the cost-effectiveness of "prevention as prevention"Elliot Marseille, James G Kahn
AIDS (London, England)|January 11, 2000
Fighting global AIDS: the value of cost-effectiveness analysisJ G Kahn, E Marseille
Journal of General Internal Medicine|July 18, 2013
Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysisJ G Kahn, E A Marseille
Brain and Cognition|November 1, 1994
Comments on immune aspects of the Geschwind-Behan-Galaburda model and of the article of Bryden, McManus, and Bulman-FlemingA St-Marseille, C M Braun
Exploratory Research in Clinical and Social Pharmacy|February 12, 2026
Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidenceShreya Shiju, Rohan Tirumala, Elliot Marseille
AIDS (London, England)|June 14, 2013
Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving roleJames G Kahn, Elliot A Marseille
Frontiers in Psychiatry|December 22, 2022
The economics of psychedelic-assisted therapies: A research agendaElliot Marseille, Stefano Bertozzi, James G Kahn
Environmental Technology|May 10, 2002
Use of leaching chambers for on-site sewage treatmentJ G St Marseille, B C Anderson
Plos Medicine|December 30, 2006
Cost-effectiveness of male circumcision for HIV prevention in a South African settingJames G Kahn, Elliot Marseille, Bertran Auvert
AIDS (London, England)|June 19, 1998
Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan AfricaE Marseille, J G Kahn, J Saba
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
The Lancet. Global Health|October 12, 2014
Avahan and the cost-effectiveness of "prevention as prevention"Elliot Marseille, James G Kahn
AIDS (London, England)|January 11, 2000
Fighting global AIDS: the value of cost-effectiveness analysisJ G Kahn, E Marseille
Journal of General Internal Medicine|July 18, 2013
Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysisJ G Kahn, E A Marseille
Brain and Cognition|November 1, 1994
Comments on immune aspects of the Geschwind-Behan-Galaburda model and of the article of Bryden, McManus, and Bulman-FlemingA St-Marseille, C M Braun
Exploratory Research in Clinical and Social Pharmacy|February 12, 2026
Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidenceShreya Shiju, Rohan Tirumala, Elliot Marseille
AIDS (London, England)|June 14, 2013
Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving roleJames G Kahn, Elliot A Marseille
Frontiers in Psychiatry|December 22, 2022
The economics of psychedelic-assisted therapies: A research agendaElliot Marseille, Stefano Bertozzi, James G Kahn
Environmental Technology|May 10, 2002
Use of leaching chambers for on-site sewage treatmentJ G St Marseille, B C Anderson
Plos Medicine|December 30, 2006
Cost-effectiveness of male circumcision for HIV prevention in a South African settingJames G Kahn, Elliot Marseille, Bertran Auvert
AIDS (London, England)|June 19, 1998
Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan AfricaE Marseille, J G Kahn, J Saba
Pageof 13